Modern Healthcare, July 25, 2015. More than 19,000 women have joined a Facebook support group called Essure Problems. Many have reported debilitating abdominal pain, heavy bleeding and large weight fluctuations. They claim these side effects were not disclosed to them by the manufacturer or their doctors, and that their complaints have been dismissed for years by the device manufacturer, physicians and the federal government.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
CMS Panel Moderately Confident that some PAD Treatments Warrant National Coverage
Healio, July 22, 2015. “We have a conflict between what we know logically should work [and] data that … just aren’t very good,” panel member Diana Zuckerman, PhD, president of the National Center for Health Research Cancer Prevention and Treatment Fund, said. She was one of several panelists who emphasized the need for more long-term data.
Read More »After Health Care Act, Sharp Drop in Spending on Birth Control
The New York Times, July 7, 2015. Out-of-pocket spending on most major birth control methods fell sharply in the months after the Affordable Care Act began requiring insurance plans to cover contraception at no cost to women, a new study has found.
Read More »House Overwhelmingly Passes 21st Century Cures Act
Modern Healthcare, July 10, 2015. In a rare act of bipartisanship, House members voted 344-77 on Friday in favor of the 21st Century Cures Act, which supporters say will speed the development and regulatory approval of medical breakthroughs. Critics say that speed would come at the expense of patients’ safety.
Read More »Hope For Children’s Rare Drug Approval Process
USA Today (Kaiser Health News), June 7, 2015. A reward program is an extension of the 21st Century Cures bill, which seeks to rewrite the rules for drug development to make innovative treatments available faster.
Read More »